A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee
Public ClinicalTrials.gov record NCT04683627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee
Study identification
- NCT ID
- NCT04683627
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 370 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 29, 2020 (Actual)
- Primary completion
- Jul 18, 2022 (Actual)
- Completion
- Jul 25, 2022 (Actual)
- Last update posted
- Sep 4, 2025
2020 – 2022
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Applied Research Center of Arkansas | Little Rock | Arkansas | 72212 | — |
| Clinical Research of West Florida,Inc. | Clearwater | Florida | 33765 | — |
| Universal Axon Clinical Research, LLC | Doral | Florida | 33166 | — |
| The Arthritis and Diabetes Clinic, Inc. | Monroe | Louisiana | 71203 | — |
| Noven Pharmaceuticals, Inc. | Jersey City | New Jersey | 07310 | — |
| Velocity Clinical Research | Cincinnati | Ohio | 45242 | — |
| Partners in Clinical Research | Cumberland | Rhode Island | 02864 | — |
| Palmetto Clinical Research | Summerville | South Carolina | 29485 | — |
| Metroplex Clinical Research Center | Dallas | Texas | 75231 | — |
| Quality Research Inc. | San Antonio | Texas | 78209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04683627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04683627 live on ClinicalTrials.gov.